A rare functional cardioprotective APOC3 variant has risen in frequency in distinct population isolates
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Isolated populations can empower the identification of rare variation associated with complex traits through next generation association studies, but the generalizability of such findings remains unknown. Here we genotype 1,267 individuals from a Greek population isolate on the Illumina HumanExome Beadchip, in search of functional coding variants associated with lipids traits. We find genome-wide significant evidence for association between R19X, a functional variant in APOC3, with increased high-density lipoprotein and decreased triglycerides levels. Approximately 3.8% of individuals are heterozygous for this cardioprotective variant, which was previously thought to be private to the Amish founder population. R19X is rare (<0.05% frequency) in outbred European populations. The increased frequency of R19X enables discovery of this lipid traits signal at genome-wide significance in a small sample size. This work exemplifies the value of isolated populations in successfully detecting transferable rare variant associations of high medical relevance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genome-wide efficient mixed-model analysis for association studies
Zhou, X., & Stephens, M. (2012) · Nature Genetics · doi:10.1038/ng.2310 · Cited by 3,627
Biological, clinical and population relevance of 95 loci for blood lipids
Teslovich, T. M., Musunuru, K., Smith, A. V., Edmondson, A. C., Stylianou, I. M., Koseki, M., Pirruccello, J. P., Ripatti, S., Chasman, D. I., Willer, C. J., et al. (2010) · Nature · doi:10.1038/nature09270 · Cited by 3,487
Self-citationIntegrating common and rare genetic variation in diverse human populations
The International HapMap 3 Consortium (2010) · Nature · doi:10.1038/nature09298 · Cited by 3,026
Pollin, T. I., Damcott, C. M., Shen, H., Ott, S. H., Shelton, J., Horenstein, R. B., Post, W., McLenithan, J. C., Bielak, L. F., Peyser, P. A., et al. (2008) · Science · doi:10.1126/science.1161524 · Cited by 688
Self-citationDetection of sharing by descent, long-range phasing and haplotype imputation
Kong, A., Masson, G., Frigge, M. L., Gylfason, A., Zusmanovich, P., Thorleifsson, G., Olason, P. I., Ingason, A., Steinberg, S., Rafnar, T., et al. (2008) · Nature Genetics · doi:10.1038/ng.216 · Cited by 447
Li, W. W., Dammerman, M. M., Smith, J. D., Metzger, S., Breslow, J. L., & Leff, T. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118324 · Cited by 278
zCall: a rare variant caller for array-based genotyping
Goldstein, J. I., Crenshaw, A., Carey, J., Grant, G. B., Maguire, J., Fromer, M., O’Dushlaine, C., Moran, J. L., Chambert, K., Stevens, C., et al. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts479 · Cited by 196
Research works printed but not linked: 23
- Peltonen, L., Palotie, A. & Lange, K. Use of population isolates for mapping complex traits. Nat. Rev. Genet. 1, 182–190 (2000). · DOI · Paper page
- Zeggini, E. Next-generation association studies for complex traits. Nat. Genet. 43, 287–288 (2011). · DOI · Paper page
- Huyghe, J. R. et al. Exome array analysis identifies new loci and low-frequency variants influencing insulin processing and secretion. Nat. Genet. 45, 197–201 (2013). · DOI · Paper page
- Keys, A. Coronary Heart Disease in seven countries. Circulation 41, 1–211 (1970). · DOI · Paper page
- Menotti, A. et al. Food intake patterns and 25-year mortality from coronary heart disease: cross-cultural correlations in the Seven Countries Study. The Seven Countries Study Research Group. Eur. J. Epidemiol. 15, 507–515 (1999). · DOI · Paper page
- Renaud, S. et al. Cretan Mediterranean diet for prevention of coronary heart disease. Am. J. Clin. Nutr. 61, 1360S–1367S (1995). · DOI · Paper page
- Aulchenko, Y. S. et al. Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat. Genet. 41, 47–55 (2009). · DOI · Paper page
- Kathiresan, S. et al. Common variants at 30 loci contribute to polygenic dyslipidemia. Nat. Genet. 41, 56–65 (2009). · DOI · Paper page
- Ridker, P. M. et al. Polymorphism in the CETP gene region, HDL cholesterol, and risk of future myocardial infarction: genomewide analysis among 18 245 initially healthy women from the Women’s Genome Health Study. Circ. Cardiovasc. Genet. 2, 26–33 (2009). · DOI · Paper page
- Smith, E. N. et al. Longitudinal genome-wide association of cardiovascular disease risk factors in the Bogalusa heart study. PLoS Genet. 6, (2010). · DOI · Paper page
- Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285, 2486–2497 (2001). · DOI · Paper page
- Abecasis, G. R. et al. An integrated map of genetic variation from 1,092 human genomes. Nature 491, 56–65 (2012). · DOI · Paper page
- Fu, W. et al. Analysis of 6,515 exomes reveals the recent origin of most human protein-coding variants. Nature 493, 216–220 (2013). · DOI · Paper page
- Luttmann, S. et al. Electrophoretic screening for genetic variation in apolipoprotein C-III: identification of a novel apoC-III variant, apoC-III(Asp45-->Asn), in a Turkish patient. J. Lipid. Res. 35, 1431–1440 (1994). · DOI · Paper page
- Maeda, H., Hashimoto, R. K., Ogura, T., Hiraga, S. & Uzawa, H. Molecular cloning of a human apoC-III variant: Thr 74—Ala 74 mutation prevents O-glycosylation. J. Lipid. Res. 28, 1405–1409 (1987). · DOI · Paper page
- Pullinger, C. R. et al. A novel apolipoprotein C-III variant, apoC-III(Gln38—>Lys), associated with moderate hypertriglyceridemia in a large kindred of Mexican origin. J. Lipid. Res. 38, 1833–1840 (1997). · DOI
- von Eckardstein, A. et al. Apolipoprotein C-III(Lys58—Glu). Identification of an apolipoprotein C-III variant in a family with hyperalphalipoproteinemia. J. Clin. Invest. 87, 1724–1731 (1991). · DOI · Paper page
- Xu, C. F. et al. Association between genetic variation at the APO AI-CIII-AIV gene cluster and familial combined hyperlipidaemia. Clin. Genet. 46, 385–397 (1994). · DOI · Paper page
- Dammerman, M., Sandkuijl, L. A., Halaas, J. L., Chung, W. & Breslow, J. L. An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3' untranslated region polymorphisms. Proc. Natl Acad. Sci. USA 90, 4562–4566 (1993). · DOI · Paper page
- Talmud, P. J. et al. Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides. Hum. Mol. Genet. 11, 3039–3046 (2002). · DOI · Paper page
- Waterworth, D. M. et al. Variants in the APOC3 promoter insulin responsive element modulate insulin secretion and lipids in middle-aged men. Biochim. Biophys. Acta. 1637, 200–206 (2003). · DOI
- Atzmon, G. et al. Lipoprotein genotype and conserved pathway for exceptional longevity in humans. PLoS Biol. 4, e113 (2006). · DOI · Paper page
- Friedewald, W. T., Levy, R. I. & Fredrickson, D. S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18, 499–502 (1972). · DOI · Paper page
Cited by
ARUK Consortium, Sims, R., GERAD/PERADES, C., van der Lee, S. J., Naj, A. C., Bellenguez, C., Badarinarayan, N., Jakobsdottir, J., Kunkle, B. W., Boland, A., et al. (2017) · Nature Genetics · doi:10.1038/ng.3916 · Cited by 1,012
Self-citationThe power of genetic diversity in genome-wide association studies of lipids
Graham, S. E., Clarke, S. L., Wu, K.-H. H., Kanoni, S., Zajac, G. J. M., Ramdas, S., Surakka, I., Ntalla, I., Vedantam, S., Winkler, T. W., et al. (2021) · Nature · doi:10.1038/s41586-021-04064-3 · Cited by 972
Self-citationGenomics of disease risk in globally diverse populations
Gurdasani, D., Barroso, I., Zeggini, E., & Sandhu, M. S. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-019-0144-0 · Cited by 306
Self-citationThe Roles of ApoC-III on the Metabolism of Triglyceride-Rich Lipoproteins in Humans
Borén, J., Packard, C. J., & Taskinen, M.-R. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00474 · Cited by 196
“Carriers of the APOC3 null mutation R19X variant are rare Frontiers in Endocrinology | www.frontiersin.org 4 July 2020 | Volume 11 | Article 474 [0.08% in Americans (98) and 0.05% in Europeans (99)], but the R19X variant is enriched in the Amish population and in an isolated cohort on the island of Crete (100).”
BackgroundInfluentialCarmi, S., Hui, K. Y., Kochav, E., Liu, X., Xue, J., Grady, F., Guha, S., Upadhyay, K., Ben-Avraham, D., Mukherjee, S., et al. (2014) · Nature Communications · doi:10.1038/ncomms5835 · Cited by 188
Metadata
- Authors
- Tachmazidou, I., Dedoussis, G., Southam, L., Farmaki, A.-E., Ritchie, G. R. S., Xifara, D. K., Matchan, A., Hatzikotoulas, K., Rayner, N. W., Chen, Y., Pollin, T. I., O’Connell, J. R., Yerges-Armstrong, L. M., Kiagiadaki, C., Panoutsopoulou, K., Schwartzentruber, J., Moutsianas, L., UK10K consortium, Tsafantakis, E., Tyler-Smith, C., McVean, G., Xue, Y., & Zeggini, E.
- Venue
- Nature Communications
- Published
- 2013-12-17
- Volume
- 4
- Issue
- 1
- Pages
- 2872-2872
- ISSN
- 2041-1723 (ISSN-L)
- OpenAlex
- W2026187919
- Cited by
- 96
- References
- 7
- FWCI
- 7.84
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A rare functional cardioprotective APOC3 variant has risen in frequency in distinct population isolates. https://app.cochat.ai/papers/10.1038/ncomms3872
- The paper
- Tachmazidou, I., Dedoussis, G., Southam, L., Farmaki, A.-E., Ritchie, G. R. S., Xifara, D. K., Matchan, A., Hatzikotoulas, K., Rayner, N. W., Chen, Y., Pollin, T. I., O’Connell, J. R., Yerges-Armstrong, L. M., Kiagiadaki, C., Panoutsopoulou, K., Schwartzentruber, J., Moutsianas, L., UK10K consortium, Tsafantakis, E., . . . Zeggini, E. (2013). A rare functional cardioprotective APOC3 variant has risen in frequency in distinct population isolates. Nature Communications. https://doi.org/10.1038/ncomms3872
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.